Molecular Determinants of Ethionamide Resistance in Clinical Isolates of Mycobacterium tuberculosis
Sign Up to like & getrecommendations! Published in 2022 at "Antibiotics"
DOI: 10.3390/antibiotics11020133
Abstract: Background: Ethionamide and prothionamide are now included in group C of the WHO recommended drugs for the treatment of tuberculosis resistant to rifampicin and multidrug-resistant tuberculosis. The clinical relevance of ethionamide and prothionamide has increased… read more here.
Keywords: clinical isolates; tuberculosis; ethionamide resistance; molecular determinants ... See more keywords
Phenotypic low-level isoniazid resistance as a marker to predict ethionamide resistance in Mycobacterium tuberculosis
Sign Up to like & getrecommendations! Published in 2017 at "International Journal of Mycobacteriology"
DOI: 10.4103/ijmy.ijmy_34_17
Abstract: Background: Tuberculosis is one of the most prevalent diseases in Pakistan. Pakistan has the highest burden of MDR-TB in the Eastern Mediterranean region. Ethionamide is an anti-tuberculous drug frequently used to treat MDR-TB. Its drug… read more here.
Keywords: isoniazid; isoniazid resistance; ethionamide resistance; resistance ... See more keywords